These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 7507230)

  • 21. Characterization and functional analysis of the p42Ets-1 variant of the mouse Ets-1 transcription factor.
    Lionneton F; Lelièvre E; Baillat D; Stehelin D; Soncin F
    Oncogene; 2003 Dec; 22(57):9156-64. PubMed ID: 14668797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of ETS1 in IL-2 gene expression.
    Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
    J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
    Mignotte V; Deveaux S; Filipe A
    Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.
    Watson DK; Smyth FE; Thompson DM; Cheng JQ; Testa JR; Papas TS; Seth A
    Cell Growth Differ; 1992 Oct; 3(10):705-13. PubMed ID: 1445800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.
    Seth A; Papas TS
    Oncogene; 1990 Dec; 5(12):1761-7. PubMed ID: 2284095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
    Wasylyk B; Wasylyk C; Flores P; Begue A; Leprince D; Stehelin D
    Nature; 1990 Jul; 346(6280):191-3. PubMed ID: 2114554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
    Cheng YH; Handwerger S
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One of two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins.
    Fujimura Y; Yamamoto H; Hamazato F; Nozaki M
    Nucleic Acids Res; 1994 Feb; 22(4):613-8. PubMed ID: 7510396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
    Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
    Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing.
    Jorcyk CL; Watson DK; Mavrothalassitis GJ; Papas TS
    Oncogene; 1991 Apr; 6(4):523-32. PubMed ID: 2030910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
    Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
    Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
    Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
    Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETS1 transactivates the human GM-CSF promoter in Jurkat T cells stimulated with PMA and ionomycin.
    Thomas RS; Tymms MJ; Seth A; Shannon MF; Kola I
    Oncogene; 1995 Nov; 11(10):2135-43. PubMed ID: 7478534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of human T cell receptor beta gene expression by Ets-1.
    Wotton D; Prosser HM; Owen MJ
    Leukemia; 1993 Aug; 7 Suppl 2():S55-60. PubMed ID: 8361234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity.
    Nerlov C; Rørth P; Blasi F; Johnsen M
    Oncogene; 1991 Sep; 6(9):1583-92. PubMed ID: 1923525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regulation of T cell antigen receptor alpha chain gene expression].
    Kantake M
    Arerugi; 1992 Apr; 41(4):532-42. PubMed ID: 1535773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.